These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7625818)

  • 1. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii.
    Vila J; Ruiz J; Goñi P; Marcos A; Jimenez de Anta T
    Antimicrob Agents Chemother; 1995 May; 39(5):1201-3. PubMed ID: 7625818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.
    Liu YH; Kuo SC; Lee YT; Chang IC; Yang SP; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Apr; 45(2):108-12. PubMed ID: 22153765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii.
    Vila J; Ruiz J; Goñi P; Jimenez de Anta T
    J Antimicrob Chemother; 1997 Jun; 39(6):757-62. PubMed ID: 9222045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.
    Ouabdesselam S; Hooper DC; Tankovic J; Soussy CJ
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1667-70. PubMed ID: 7486897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates.
    Vila J; Ribera A; Marco F; Ruiz J; Mensa J; Chaves J; Hernandez G; Jimenez De Anta MT
    J Antimicrob Chemother; 2002 Mar; 49(3):471-7. PubMed ID: 11864947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of distinct ciprofloxacin susceptibility in Acinetobacter spp. by detection of the gyrA gene mutation using real-time PCR.
    Sheng WH; Lin YC; Wang JT; Chen YC; Chang SC; Hsia KC; Wu RJ; Li SY
    Mol Cell Probes; 2009; 23(3-4):154-6. PubMed ID: 19281841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
    Navia MM; Ruiz J; Ribera A; de Anta MT; Vila J
    J Antimicrob Chemother; 1999 Dec; 44(6):743-8. PubMed ID: 10590274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance mechanism of Acinetobacter spp. strains resistant to DW-116, a new quinolone.
    Choi KH; Baek MC; Kim BK; Choi EC
    Arch Pharm Res; 1998 Jun; 21(3):310-4. PubMed ID: 9875449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetii.
    Musso D; Drancourt M; Osscini S; Raoult D
    Antimicrob Agents Chemother; 1996 Apr; 40(4):870-3. PubMed ID: 8849242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gyrA mutations in quinolone-resistant isolates of the fish pathogen Aeromonas salmonicida.
    Oppegaard H; Sørum H
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2460-4. PubMed ID: 7840589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility.
    Valdezate S; Vindel A; Echeita A; Baquero F; Cantó R
    Antimicrob Agents Chemother; 2002 Mar; 46(3):665-71. PubMed ID: 11850246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of antibiotic resistance and sequence type of Acinetobacter baumannii clinical isolates in Japan and the antibacterial activity of DS-8587.
    Higuchi S; Shikata M; Chiba M; Hoshino K; Gotoh N
    J Infect Chemother; 2014 Apr; 20(4):256-61. PubMed ID: 24709045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance.
    Goñi-Urriza M; Arpin C; Capdepuy M; Dubois V; Caumette P; Quentin C
    Antimicrob Agents Chemother; 2002 Feb; 46(2):350-9. PubMed ID: 11796341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B; Gill A; Amyes SG; Gülay Z
    Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in gyrA and parC QRDRs are not relevant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates.
    Ribera A; Doménech-Sanchez A; Ruiz J; Benedi VJ; Jimenez de Anta MT; Vila J
    Microb Drug Resist; 2002; 8(4):245-51. PubMed ID: 12523620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.
    Ling JM; Chan EW; Lam AW; Cheng AF
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3567-73. PubMed ID: 14576119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations.
    Takiff HE; Salazar L; Guerrero C; Philipp W; Huang WM; Kreiswirth B; Cole ST; Jacobs WR; Telenti A
    Antimicrob Agents Chemother; 1994 Apr; 38(4):773-80. PubMed ID: 8031045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.